QL-X-138 HCl is a novel selective and highly potent BTK/MNK dual-kinase inhibitor with anticancer activity that binds covalently to BTK and noncovalently to MNK. QL-X-138 HCl inhibited BTK, MNK1, and MNK2 kinases. QL-X-138 HCl has anti-dengue virus 2 activity and shows anti-proliferative activity in acute myeloid leukemia cells. QL-X-138 HCl can be used to study lymphoma and leukemia.
Molecular Weight:
457.91
Purity:
99.25%
Formula:
C25H20ClN5O2
Target:
MNK|||BTK
T38960L
* VAT and and shipping costs not included. Errors and price changes excepted